GODMET G1 & G2
In T2DM Patients uncontrolled on monotherapy
- Combination reduces A1C more than either drug alone
- Decrease in A1C concentration
- SU plus (sul + met) met offers greater reduction in HbA1C than incretin with no difference in hypoglycaemia.
- Decreases HbA1C by 1.2 - 1.9 % in patients with T2DM mellitus.
- Prevents cardiovascular complications
- A combination of glimepiride with metformin achieves good glycemic control.
- Higher bioavailability, longer duration of action - better tolerability.
Our all Products
Find Me
- Ramchandra Niwas, Near Shastra House, Anand Koliwada, Mumbra, Thane(Dt), Maharastra, India - 400612
- 1800 309 7607
- info@bageo.in
- R.O: 108, Ground Floor, Lakshmi Street, Thirumal Nagar, Reddiyur, Salem.